Ireland Judgment

3i/ Alpharma [2008] IECompA m08004 (22 February 2008)

On this page

Professional case brief

Research organized from the available case record

Source document

01

Holding and result

The Competition Authority found that the proposed acquisition would not substantially lessen competition in the pharmaceutical sector and cleared the merger in Phase 1.

Court disposition

Cleared

Orders

  • The proposed acquisition by 3i Group plc of the active pharmaceutical ingredients business of Alpharma Inc. is cleared under Phase 1.

02

Material facts

Parties

3i Group plc

Acquirer

Alpharma Inc.

Target

03

Procedural history

  1. Posture

    Merger Notification / Phase 1 Clearance

04

Questions and positions

Legal issues

Whether the proposed acquisition would substantially lessen competition in the pharmaceutical sector

Party arguments

Applicant
The acquisition would not adversely affect competition in the relevant market.
Respondent
No opposition or adverse argument presented.

05

Court’s reasoning

  1. 01

    Competition Act 2002 (Ireland)

    Assessment of mergers under Irish competition law to prevent substantial lessening of competition.

06

Ratio, limits and disposition

Ratio decidendi

The Competition Authority found that the proposed acquisition would not substantially lessen competition in the pharmaceutical sector and cleared the merger in Phase 1.

Court disposition

Cleared

  • The proposed acquisition by 3i Group plc of the active pharmaceutical ingredients business of Alpharma Inc. is cleared under Phase 1.

Source and reliance status

Official court record

This page organises the available record for research. Confirm quotations, current status, and subsequent treatment against the official source before relying on the case.

Judgment reading view

Judgment text

The complete available source text.

Source document

Court record

Judgment

Judgment

[ Home ] [ Databases ] [ World Law ] [ Multidatabase Search ] [ Help ] [ Feedback ] [

DONATE ] Irish Competition Authority Decisions You are here:

BAILII >> Databases >> Irish Competition Authority Decisions >> 3i/ Alpharma [2008] IECompA m08004 (22 February 2008) URL: https://www.bailii.org/ie/cases/IECompA/2008/m08004.html Cite as: [2008] IECompA m8004, [2008] IECompA m08004 [ New search ] [ Help ] 3i/ Alpharma [2008] IECompA m08004 (22 February 2008) Page Attachment M08004.3i. Public_0.pdf (81.07 KB) (81.07 KB) M08004.3i. Public.pdf (81.07 KB) (81.07 KB) Transaction details Proposed acquisition by 3i Group plc. of the active pharmaceutical ingredients business of Alpharman Inc. Economic sector Media merger Pharmaceuticals No Notification date: Friday, February 22, 2008 Parties Involved Business activities Bewleys Manufacturing Ltd Butlers Irish Confectionery Ltd Investment management. Others [Chez Nous Ltd, Sorenson family, and Bewley’s Cafes Ltd] pharmaceuticals 3i Alpharma Case Officer Assigned Contact Details Barry O'Donnell 01-804 5396, bod@tca.ie The deadline for any third parties who wish to make submissions regarding the competition aspects of this merger is: Phase 1 Monday, March 3, 2008 Current status Completed Cleared (Phase 1) Decision date: Thursday, March 13, 2008 Competition and Consumer Protection Commission (Ireland) © BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII URL: https://www.bailii.org/ie/cases/IECompA/2008/m08004.html

Source wording is retained. Consult the source document for its original formatting and pagination.

Authorities

Authorities used by the court

Cases, legislation, regulations, and constitutional provisions identified in the available record.

Competition Act 2002 (Ireland)

Legislation

Legislation referenced in the available case record.

Case-aware research

Ask AI about this case

The judgment and available research above are public. New questions open in a separate private conversation grounded in this case.

About this LexChat collection

This page organizes the available case record for research. Verify quotations, current status, and subsequent treatment against the source document. Corrections can be reported to hello@esheria.ai.

Legal information, not legal advice. Research summaries do not replace the judgment.